EASD Highlights

touchENDOCRINOLOGY caught up with Prof Gian Paolo Fadini (University Hospital of Padova, Italy) virtually during the EASD Annual Meeting 2021 conference to discuss the real-world data from the RESTORE-2 study. Questions 1. What have randomized controlled trials taught us about the efficacy and safety of second-generation basal insulins? (00:18-01:31) 2. What were the aims, design […]

touchENDOCRINOLOGY caught up with Anna-Maria Lampousi (Karolinska Institutet, Stockholm, Sweden) virtually during the EASD Annual Meeting 2021 conference to discuss her systematic review and meta-analysis on dietary factors and risk of islet autoimmunity and type 1 diabetes. Questions 1. What is known about the associations between dietary components and type 1 diabetes, and what gaps […]

touchENDOCRINOLOGY caught up with Prof Lise Lotte Gluud (Copenhagen University Hospital, Hvidovre, Denmark) virtually during the EASD Annual Meeting 2021 conference to discuss her study on the effect of subcutaneous semaglutide on features of the metabolic syndrome in patients with non-alcoholic steatohepatitis. Questions 1. Could you give us a brief overview of the association of […]

We spoke with Prof. Juliana Chan (The Chinese University of Hong Kong, Hong Kong) following her session on COVID-19 and the impact on patients with type 1 diabetes. Questions What key areas of diabetes and COVID-19 were discussed at EASD 2020? (0:05) How do you think the COVID-19 pandemic has affected treatment both now and […]

We were delighted to speak with Prof. Tina Vilsbøll (University of Copenhagen, Copenhagen, Denmark) about the approval of semaglutide and the impact on the GLP-1RA landscape, and the movement towards individualizing care in patients with type 2 diabetes. Questions What has been the impact of the approval of oral semaglutide in the GLP-1RA landscape? (0:15) […]

We were delighted to speak with Dr Gian Paolo Fadini (University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy) about his highlights from the virtual EASD 2020 meeting.   Disclosures: Dr Gian Paolo Fadini has received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp and Dohme, Mundipharma, Novartis Novo Nordisk, Sanofi […]

We were delighted to catch-up with Dr Gian Paolo Fadini (University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy) to talk about his Minkowski Lecture on bone marrow, circulating stem cells and diabetes.   Disclosures: Dr Gian Paolo Fadini has received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp and Dohme, […]

We caught up with Dr Mathias Ried-Larsen (Centre for Physical Activity Research, Rigshospitalet) to discuss the results of his study into the effects of cycling on all-cause and cardiovascular mortality among people with diabetes. Questions Tell us about your study into the effects of cycle training on all-cause and cardiovascular mortality? (0:06) What challenges affect […]

Prof. Frank Snoek (Amsterdam University Medical Centers, Amsterdam, The Netherlands) founder and member of the PSAD Study Group, discusses the key psychosocial issues patients face on a daily basis and during the COVID-19 pandemic. Disclosures: Prof. Frank Snoek has nothing to disclose. Support: Interview and filming supported by Touch Medical Media. Filmed as a highlight […]